ArticlePloS one2015
West Nile Virus Seroprevalence in the Greek Population in 2013: A Nationwide Cross-Sectional Survey.
Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Modelling the risk of West Nile virus infection in seven European countries from published serological and case notification data, 2008 to 2022.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026Pooled it
- West Nile Virus Infection in Occupational Settings-A Systematic Review.Pathogens (Basel, Switzerland) · 2024Pooled it
- Patterns of emergence and circulation of West Nile Virus in Algeria.Nature communications · 2026Article
- Seroprevalence of West Nile virus, Greece, 2020.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025Article
- Early warning system of the seasonal west nile virus infection risk in humans in northern greece, 2020-2024.Scientific reports · 2025Article
- Unveiling spatial patterns of West Nile virus emergence in northern Greece, 2010-2023.One health (Amsterdam, Netherlands) · 2024Article
- An Assessment of West Nile and Usutu Viruses' Seroprevalence in Hospitalized Patients: A Preliminary Study on Flavivirus Exposure in Eastern Romania.Pathogens (Basel, Switzerland) · 2024Article
- West Nile virus spread in Europe: Phylogeographic pattern analysis and key drivers.PLoS pathogens · 2024Article
- West Nile, Sindbis and Usutu Viruses: Evidence of Circulation in Mosquitoes and Horses in Tunisia.Pathogens (Basel, Switzerland) · 2023Article
- Article
- Seroprevalence Rates against West Nile, Usutu, and Tick-Borne Encephalitis Viruses in Blood-Donors from North-Western Romania.International journal of environmental research and public health · 2022Article
- West Nile Virus Seroprevalence in Manisa Province: A Population-based Study.Infectious diseases & clinical microbiology · 2022Article
- West Nile and Usutu virus seroprevalence in Hungary: A nationwide serosurvey among blood donors in 2019.PloS one · 2022Article
- A climate-dependent spatial epidemiological model for the transmission risk of West Nile virus at local scale.One health (Amsterdam, Netherlands) · 2021Article
- Seasonal Phenological Patterns and Flavivirus Vectorial Capacity of Medically Important Mosquito Species in a Wetland and an Urban Area of Attica, Greece.Tropical medicine and infectious disease · 2021Article
- West Nile Virus Seroprevalence in the Italian Tuscany Region from 2016 to 2019.Pathogens (Basel, Switzerland) · 2021Article
- Evidence of West Nile Virus Circulation in Lebanon.Viruses · 2021Article
- Evaluation of Two Chemiluminescent and Three ELISA Immunoassays for the Detection of SARS-CoV-2 IgG Antibodies: Implications for Disease Diagnosis and Patients' Management.Frontiers in immunology · 2020Article
- Serosurvey for dengue virus infection among pregnant women in the West Nile virus enzootic community of El Paso Texas.PloS one · 2020Article
- Seropositivity of West Nile Virus Among Acute Febrile Patients in Southern Ethiopia.Infection and drug resistance · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cases of West Nile Virus (WNV) disease were recorded for three consecutive years in Greece following the year 2010 outbreak. A cross-sectional serologic survey was conducted to estimate the WNV seroprevalence and assess the ratio of infection to neuroinvasive disease. A stratified left-over sampling methodology was used including age and residence strata. A total of 3,962 serum samples was collected and tested for WNV Immunoglobulin G (IgG) antibodies by Enzyme-Linked Immunosorbent Assay (ELISA). All positive samples were further tested by Plaque Reduction Neutralization Test (PRNT) and WNV Immunoglobulin M (IgM) antibodies. WNV IgG antibodies were detected in 82 samples and 61 were also positive in PRNT representing a weighted seroprevalence of 2.1% (95% C.I.: 1.7-2.6) and 1.5% (95% C.I.: 1.2-2.0), respectively. Multivariable analysis showed that seroprevalence was associated with age and residence. The overall ratio of neuroinvasive disease to infected persons was estimated at 1:376 (95% C.I.: 1:421-1:338), while the elderly people had the highest ratio. This nationwide study provided valuable data regarding the epidemiology of WNV in Greece based on the fact that elderly people have higher risk of being both infected and having severe disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.